2014
DOI: 10.1021/bi500711x
|View full text |Cite
|
Sign up to set email alerts
|

Thermodynamics of Binding of Structurally Similar Ligands to Histone Deacetylase 8 Sheds Light on Challenges in the Rational Design of Potent and Isozyme-Selective Inhibitors of the Enzyme

Abstract: Among the different histone deacetylase (HDAC) isozymes, HDAC8 is the most highly malleable enzyme, and it exhibits the potential to accommodate structurally diverse ligands (albeit with moderate binding affinities) in its active site pocket. To probe the molecular basis of this feature, we performed detailed thermodynamic studies of the binding of structurally similar ligands, which differed with respect to the “cap”, “linker”, and “metal-binding” regions of the suberoylanilide hydroxamic acid (SAHA) pharmaco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 87 publications
0
14
0
Order By: Relevance
“…In contrast to SAHA and DCPI, binding of the inhibitor Trichostatin A (TSA) with an unsaturated chain and a more polar cap-group, led to substantial and distinct chemical shift changes; Fig. 1c, e. Previous investigations have shown that TSA binds to HDAC8 in a 1:1 stoichiometry in solution 31 . Upon sub-stoichiometric addition of TSA the cross-peaks split into two fractions, revealing that the binding reaction is in the intermediate-to-slow exchange regime 32 in agreement with previous reports 33,34 .…”
Section: Resultsmentioning
confidence: 94%
See 1 more Smart Citation
“…In contrast to SAHA and DCPI, binding of the inhibitor Trichostatin A (TSA) with an unsaturated chain and a more polar cap-group, led to substantial and distinct chemical shift changes; Fig. 1c, e. Previous investigations have shown that TSA binds to HDAC8 in a 1:1 stoichiometry in solution 31 . Upon sub-stoichiometric addition of TSA the cross-peaks split into two fractions, revealing that the binding reaction is in the intermediate-to-slow exchange regime 32 in agreement with previous reports 33,34 .…”
Section: Resultsmentioning
confidence: 94%
“…1c, e . Previous investigations have shown that TSA binds to HDAC8 in a 1:1 stoichiometry in solution 31 . Upon sub-stoichiometric addition of TSA the cross-peaks split into two fractions, revealing that the binding reaction is in the intermediate-to-slow exchange regime 32 in agreement with previous reports 33 , 34 .…”
Section: Resultsmentioning
confidence: 94%
“…All of the structural, kinetic, and thermodynamic data suggest that SAHA binds to the active site pocket of HDAC8 (28,29,32,39). Because TM-2-51 does not obliterate the binding of SAHA to the enzyme (Fig.…”
Section: Discussionmentioning
confidence: 94%
“…6), it implies that both the activator and the inhibitor (used to serve as a substrate analog) can simultaneously bind to the enzyme. This is not surprising in view of the marked malleability/flexibility of the active site pocket of HDAC8, as evident from its ability to interact with structurally diverse ligands with modest binding affinities (6,10,32,39). The kinetic (Fig.…”
Section: Discussionmentioning
confidence: 95%
“…Very recently, Wiest 18 further put forward a viewpoint that the deprotonation of SAHA in HDAC8 is "Model-dependent" (namely "QM-size" dependent) in their static QM/MM (ONIOM) calculation, in which negative SAHA is more stable if the two Asp residues (see conserved D-H dyads as shown in Figure 1) was considered in the QM region while neutral SAHA is more stable if using a smaller QM region as we used in previous study. 12 Meanwhile, on the basis of the Isothermal Titration Calorimetry (ITC) experiments in 2014, Srivastava et al 19 suggested that SAHA may release a proton to the exterior buffer upon binding to HDAC8, but as the determined enthalpy and entropy difference is tiny and thus still difficult for definitely identifying the feasibility of the proton transfer reaction between SAHA and His142 (as shown in Figure 1). Nevertheless, it is the first time to clarify the SAHA's protonation state in the enzyme-inhibitor complex experimentally.…”
Section: Saha (Vorinostat Merck) Is a Famous Clinical Drug Of Zinc-mentioning
confidence: 99%